Minimising blood loss and transfusion in contemporary hip and knee arthroplasty

Journal of Bone and Joint Surgery - Series B

Volumn 94 B, Issue 11 SUPPL.A, 2012, Pages 8-10

  Watts, C D ^a   Pagnano, M W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID;

BLEEDING; BLOOD TRANSFUSION; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

ANEMIA; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HEMOSTASIS, SURGICAL; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TRANEXAMIC ACID;

EID: 84870172202     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.94B11.30618     Document Type: Review

References (15)

1. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty: correct management of blood loss should take hidden loss into account. J Bone Joint Surg [Br] 2004;86-B:561-565. (Pubitemid 38660062)
2. No authors listed. Covance report; 2008 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries. Data on file.
3. Pedersen AB, Mehnert F, Overgaard S, Johnsen SP. Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord 2009;10:167.
4. Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005;45:1302-1307. (Pubitemid 41647794)
5. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003;31:529-537. (Pubitemid 37265248)
6. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and metaanalysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg [Br] 2011;93-B:39-46.
7. Benoni G, Lethagen S, Fredin H. The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. Thromb Res 1997;85:195-206. (Pubitemid 27145456)
8. Astedt B, Liedholm P, Wingerup L. The effect of tranexamic acid on the fibrinolytic activity of vein walls. Ann Chir Gynaecol 1978;67:203-205. (Pubitemid 9126857)
9. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012;470:2605-2612.
10. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. J Am Med Assoc 2010;304:1559-1567.
11. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New Eng J Med 2011;365:2453-2462.
12. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. New Eng J Med 1999;340:409-417. (Pubitemid 29084771)
13. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;(Epub ahead of print).
14. Weinberg JA, McGwin G Jr, Vandromme MJ, et al. Duration of red cell storage influences mortality after trauma. J Trauma 2010;69:1427-1431.
15. Boldt J. Volume replacement in the surgical patient: does the type of solution make a difference? Brit J Anaesth 2000;84:783-793. (Pubitemid 30312052)